Sagility Shares Advance Nearly 8% In Early Trade On BSE

Sagility India Limited shares rose as much as 7.9% to ₹40.22 on the Bombay Stock Exchange (BSE) with Nomura initiating coverage for the stock.

The stock saw strong buying interest in early trade following the brokerage’s note highlighting growth visibility in the US healthcare outsourcing space. At 11:07 am, Sagility shares were trading at ₹39.88 a piece on the BSE.

Healthcare-Focused Solutions Provider

Sagility operates as a healthcare-focused solutions provider with a majority of its business linked to the US market. Its revenue mix remains tilted towards insurance firms. The company derives:

• Around 90% of revenue from payers, which are US health insurance firms.

• About 10% of revenues from healthcare providers (hospitals).

The company also has a stable client base with a client retention rate standing at 95%. It had:

• 81 client groups as of Q3FY26.

• Average client tenure stood at 18 years.

Growth In The US Healthcare Outsourcing Market

Industry watchers feel Sagility is poised to benefit from the growth in the US healthcare outsourcing market, where:

• The payer segment may expand at 6–8% compound annual growth rate (CAGR) through CY28.

• The provider segment may grow faster at 11–13% CAGR through CY28.

Also, recent policy changes have added to the demand outlook. Medicaid funding cuts and stricter medical loss ratio norms have impacted margins for US insurers.

This has led companies to focus more on digital tools and automation to improve efficiency. Analysts said this shift is pushing clients towards outsourcing and outcome-based engagement models.

Also Read: D-St Rally: Investors Regain ₹9 Lakh Crore As Nifty And Sensex Soar

AI Tailwinds And Key Risks

Industry watchers also feel that the company is well-positioned to benefit from artificial intelligence (AI). According to them, while AI can handle routine tasks, complex claims and clinical decisions still need human involvement due to regulatory limits set by the Centers for Medicare & Medicaid Services.

However, analysts point towards certain risks for the company going ahead. This includes a potential slowdown in the US healthcare payer segment, any moderation in outsourcing demand, and rising competition from new players that could impact growth and margins.

Sources:

Business Standard

The Economic Times